We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$494B
AUM Growth
-$24.5B
Cap. Flow
-$42.4B
Cap. Flow %
-8.58%
Top 10 Hldgs %
29.31%
Holding
15,899
New
1,434
Increased
5,761
Reduced
6,731
Closed
1,760

Sector Composition

Rank Sector Weight
1 Technology 3.37%
2 Healthcare 3.33%
3 Consumer Discretionary 2.43%
4 Financials 2.27%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIK icon
11051
CALL
Viking Holdings
VIK
$43.7B
$84.8K ﹤0.01%
+2,500
New +$75.4K
HYMC icon
11052
CALL
Hycroft Mining Holding Corp
HYMC
$2.52B
$84.8K ﹤0.01%
35,330
+16,290
+86% +$53.2K
AIYY icon
11053
CALL
YieldMax AI Option Income Strategy ETF
AIYY
$26.3M
$84.7K ﹤0.01%
+720
New +$89.3K
VOR icon
11054
Vor Biopharma
VOR
$1.36B
$84.6K ﹤0.01%
4,232
+1,978
+88% +$64K
ORKA
11055
CALL
Oruka Therapeutics
ORKA
$7.35B
$84.6K ﹤0.01%
1,842
-2,716
-60% -$108K
RLMD icon
11056
PUT
Relmada Therapeutics
RLMD
$512M
$84.6K ﹤0.01%
28,200
-31,100
-52% -$113K
NMFC icon
11057
CALL
New Mountain Finance
NMFC
$730M
$84.5K ﹤0.01%
6,900
-5,400
-44% -$67.7K
MSB
11058
PUT
Mesabi Trust
MSB
$301M
$84.4K ﹤0.01%
4,900
+600
+14% +$10.4K
ULS icon
11059
PUT
UL Solutions
ULS
$15.6B
$84.4K ﹤0.01%
+2,000
New +$75.7K
NWBI icon
11060
PUT
Northwest Bancshares
NWBI
$2.31B
$84.3K ﹤0.01%
7,300
+4,000
+121% +$44K
NTRBW icon
11061
Nutriband Inc Warrant
NTRBW
$84.3K ﹤0.01%
117,052
+3,863
+3% +$3.38K
LE icon
11062
PUT
Lands' End
LE
$384M
$84.3K ﹤0.01%
6,200
-3,200
-34% -$43K
INTR icon
11063
PUT
Inter&Co
INTR
$2.29B
$84.3K ﹤0.01%
13,700
+3,300
+32% +$19K
BTAI icon
11064
PUT
BioXcel Therapeutics
BTAI
$36.7M
$84.2K ﹤0.01%
4,113
-743
-15% -$24.9K
CRDF icon
11065
PUT
Cardiff Oncology
CRDF
$74.9M
$84.1K ﹤0.01%
37,900
+18,200
+92% +$68.6K
ELVN icon
11066
CALL
Enliven Therapeutics
ELVN
$4.31B
$84.1K ﹤0.01%
+3,600
New +$75.8K
CXH
11067
DELISTED
MFS Investment Grade Municipal Trust
CXH
$84.1K ﹤0.01%
+10,641
New +$80.3K
USMV icon
11068
PUT
iShares MSCI USA Min Vol Factor ETF
USMV
$24.5B
$84K ﹤0.01%
1,000
+900
+900% +$74.2K
LGF.A
11069
PUT
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$83.8K ﹤0.01%
8,900
-11,600
-57% -$112K
API
11070
Agora
API
$392M
$83.7K ﹤0.01%
39,462
-1,462
-4% -$3.69K
RYAM icon
11071
PUT
Rayonier Advanced Materials
RYAM
$570M
$83.2K ﹤0.01%
15,300
-85,500
-85% -$416K
DXD icon
11072
PUT
ProShares UltraShort Dow 30
DXD
$42.7M
$83.2K ﹤0.01%
2,600
-5,800
-69% -$189K
ICUI icon
11073
CALL
ICU Medical
ICUI
$4.58B
$83.1K ﹤0.01%
700
-100
-13% -$10.5K
DNP icon
11074
DNP Select Income Fund
DNP
$4.14B
$83.1K ﹤0.01%
10,109
-20,373
-67% -$177K
CDRE icon
11075
Cadre Holdings
CDRE
$1.46B
$83.1K ﹤0.01%
2,476
-800,924
-100% -$26.4M

Similar funds

Ken Griffin's Q2 2024 Portfolio in Review

As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.

  • Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
  • Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
  • Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
  • Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
  • Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
  • Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
  • Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.